Prostate Cancer
Severity of hematuria effects resolution in patients treated with hyperbaric oxygen therapy for radiation-induced hematuria - Abstract
September 13, 2013
Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer - Abstract
September 13, 2013
Taxane mechanisms of action: Potential implications for treatment sequencing in metastatic castration-resistant prostate cancer - Abstract
September 12, 2013
Quality of prostate cancer care among rural men in the Veterans Health Administration - Abstract
September 12, 2013
Oncologic outcomes following radical prostatectomy in the active surveillance era - Abstract
September 12, 2013
Interdisciplinary decision making in prostate cancer therapy - 5-years' time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité Berli - Abstract
September 12, 2013
Proteomic serum profile of fatigued men receiving localized external beam radiation therapy for non-metastatic prostate cancer - Abstract
September 12, 2013
Factors related to patient-perceived satisfaction after robot-assisted radical prostatectomy based on the expanded prostate cancer index composite survey - Abstract
September 12, 2013
Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases - Abstract
September 12, 2013
Predictive value of serum bone sialoprotein and prostate-specific antigen doubling time in patients with bone metastasis of prostate cancer - Abstract
September 11, 2013
Evidence for the efficacy of enzalutamide in postchemotherapy metastatic castrate-resistant prostate cancer - Abstract
September 11, 2013
The role of intermittent androgen suppression in biochemically recurrent or newly diagnosed metastatic prostate cancer - Abstract
September 11, 2013
Phase II trial of zoledronic acid combined with androgen-deprivation therapy for treatment-naïve prostate cancer with bone metastasis - Abstract
September 11, 2013